Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

JPMorgan starts Lion Finance Group at 'overweight'

(Sharecast News) - JPMorgan Cazenove started coverage of Lion Finance Group - formerly Bank of Georgia - on Tuesday with an 'overweight' rating and 9,200p price target. It said the company offers exposure to high growth Georgian and Armenian economies with dominant market shares in consolidated banking markets.

"We expect an earnings per share compound annual growth rate of 12% across '24-27, driven by strong volume growth, which supports an NII CAGR of 13% 25-27E and is among the highest in the sector," JPM said.

"The group benefits from scale advantages with a leading cost/income ratio of circa 35% and strong digital penetration, driving adjusted return on equity of c25% on average across the next three years compared to more than 20% MT targets.

"While the shares are up c60% YTD and our FY25 forecasts are broadly in line with consensus, we do not see the earnings outlook or sustainability reflected in the group's valuation of 5.0x PE '27E (versus 5.5x pre-pandemic average) and1.1x P/TNAV '27E, with further re-rating potential if geopolitical risk premiums (including Georgia and Russia/Ukraine) decline."

At 1415 BST, the shares were up 1.8% at 7,770p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.